The reduced folate carrier (RFC) mRNA expression in urothelial and non-urothelial bladder carcinomas / Alyaa Mahmoud Abdelhaleem ; Supervised Laila Mahran , Hilde Spahn-Langguth , Khaled Abou-Aisha
Material type:
Item type | Current library | Home library | Call number | Status | Barcode | |
---|---|---|---|---|---|---|
![]() |
قاعة الثقاقات الاجنبية - الدور الثالث | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.34.M.Sc.2010.Al.R (Browse shelf(Opens below)) | Not for loan | 01010110060249000 |
Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)
Thesis (M.Sc.) - German University - Faculty of Postgraduate Studies and Scientific Research - Department of Pharmacology and Toxicology
Urinary bladder cancer (UBC) ranks ninth in worldwide cancer incidence . The majority (77%) of bladder tumours occur in men . It is the seventh most common malignancy in men and seventeenth in women² . The spectrum of bladder tumours is broad and includes urothelial (transitional) cell carcinoma (TCC) and non-urothelial carcinoma (squamous cell carcinoma [SCC] and adenocarcinoma)
There are no comments on this title.